Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Nelson

Showing results (161-170 of 196) with videos related to

Pageof 20
Sort By:
Cancer Letters|October 23, 2019
Patient-derived orthotopic xenograft models of sarcomaKentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 15, 2019
The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft modelKentaro Miyake, Takashi Higuchi, Hiromichi Oshiro, et al.
The Journal of Infectious Diseases|February 6, 2018
Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy AloneNetanya S Utay, Douglas W Kitch, Eunice Yeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2020
A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue SarcomaAnusha Kalbasi, Mitchell Kamrava, Fang-I Chu, et al.
Biochemical and Biophysical Research Communications|January 21, 2019
Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) modelKentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, et al.
Journal of Cellular Biochemistry|June 23, 2018
Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcomaTasuku Kiyuna, Yasunori Tome, Takashi Murakami, et al.
Cell Cycle (Georgetown, Tex.)|March 16, 2017
The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years agoTakashi Murakami, Tasuku Kiyuna, Kei Kawaguchi, et al.
Oncotarget|December 29, 2016
Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drugTakashi Murakami, Kentaro Igarashi, Kei Kawaguchi, et al.
Biochemical and Biophysical Research Communications|February 27, 2018
Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse modelsKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Journal of Cellular Biochemistry|May 9, 2018
Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapyKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Pageof 20

Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Cancer Letters|October 23, 2019
Patient-derived orthotopic xenograft models of sarcomaKentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 15, 2019
The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft modelKentaro Miyake, Takashi Higuchi, Hiromichi Oshiro, et al.
The Journal of Infectious Diseases|February 6, 2018
Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy AloneNetanya S Utay, Douglas W Kitch, Eunice Yeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2020
A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue SarcomaAnusha Kalbasi, Mitchell Kamrava, Fang-I Chu, et al.
Biochemical and Biophysical Research Communications|January 21, 2019
Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) modelKentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, et al.
Journal of Cellular Biochemistry|June 23, 2018
Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcomaTasuku Kiyuna, Yasunori Tome, Takashi Murakami, et al.
Cell Cycle (Georgetown, Tex.)|March 16, 2017
The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years agoTakashi Murakami, Tasuku Kiyuna, Kei Kawaguchi, et al.
Oncotarget|December 29, 2016
Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drugTakashi Murakami, Kentaro Igarashi, Kei Kawaguchi, et al.
Biochemical and Biophysical Research Communications|February 27, 2018
Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse modelsKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Journal of Cellular Biochemistry|May 9, 2018
Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapyKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Pageof 20